Tae-Yong Kim Selected Research

11-hydroxyaclacinomycin X

10/2008

Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tae-Yong Kim Research Topics

Disease

53	Neoplasms (Cancer) 04/2022 - 07/2007
51	Breast Neoplasms (Breast Cancer) 04/2022 - 12/2012
23	Stomach Neoplasms (Stomach Cancer) 12/2021 - 07/2005
10	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2022 - 01/2016
9	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2013
9	Triple Negative Breast Neoplasms 05/2019 - 03/2015
8	Colorectal Neoplasms (Colorectal Cancer) 10/2018 - 06/2011
6	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016 - 10/2011
5	Pathologic Complete Response 07/2020 - 12/2012
4	Nausea 01/2022 - 10/2016
4	Vomiting 01/2022 - 10/2016
4	Disease Progression 01/2021 - 03/2013
3	Hypesthesia (Numbness) 02/2022 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 11/2016
3	Microsatellite Instability 10/2020 - 05/2013
3	Neutropenia 12/2019 - 01/2019
3	Obesity 10/2017 - 12/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 02/2022 - 01/2018
2	Diarrhea 04/2021 - 11/2019
2	Hypersensitivity (Allergy) 01/2021 - 11/2018
2	Human Influenza (Influenza) 11/2020 - 03/2017
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 10/2016
2	Pruritus (Itching) 11/2019 - 04/2019
2	Body Weight (Weight, Body) 10/2017 - 10/2015
2	Cholangiocarcinoma 11/2016 - 10/2015
2	Weight Loss (Weight Reduction) 04/2016 - 07/2014
2	Lymphatic Metastasis 02/2016 - 07/2015
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2016 - 01/2014
1	Weight Gain 12/2021
1	Hypothyroidism 01/2021

Drug/Important Bio-Agent (IBA)

16	Hormones (Hormone)IBA 01/2021 - 03/2013
10	Trastuzumab (Herceptin)FDA Link 01/2022 - 07/2013
10	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 07/2005
10	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2016
8	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2021 - 06/2011
7	taxaneIBA 04/2022 - 07/2013
7	Gemcitabine FDA Link 01/2022 - 10/2011
7	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2014
7	AnthracyclinesIBA 01/2019 - 07/2007
6	human ERBB2 proteinIBA 01/2021 - 03/2013
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 06/2015
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 08/2016
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 07/2007
5	ErbB Receptors (EGF Receptor)IBA 04/2019 - 10/2017
4	Pharmaceutical PreparationsIBA 04/2022 - 10/2008
4	olaparibIBA 04/2022 - 03/2015
4	Docetaxel (Taxotere)FDA Link 02/2022 - 07/2005
4	PlatinumIBA 10/2021 - 06/2015
4	B7-H1 AntigenIBA 01/2021 - 11/2016
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2022 - 03/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 07/2005
3	ceralasertibIBA 01/2021 - 01/2017
3	palbociclibIBA 01/2021 - 01/2018
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2020 - 10/2017
3	Capecitabine (Xeloda)FDA Link 12/2019 - 01/2015
3	eribulin FDA Link 11/2019 - 11/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 09/2014
3	Epidermal Growth Factor (EGF)IBA 01/2019 - 11/2013
3	thiamine triphosphorate (TTP)IBA 11/2018 - 11/2016
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 01/2016
3	Biological ProductsIBA 03/2017 - 01/2014
3	Leucovorin (Folinic Acid)FDA Link 07/2016 - 05/2013
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2022 - 03/2015
2	AntiemeticsIBA 01/2022 - 01/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2016
2	Fulvestrant (Faslodex)FDA Link 01/2021 - 11/2018
2	Estrogen ReceptorsIBA 01/2021 - 04/2015
2	exemestane (Aromasin)FDA Link 12/2019 - 03/2013
2	Tamoxifen FDA LinkGeneric 12/2019 - 11/2018
2	HM781-36BIBA 11/2019 - 12/2018
2	Phenobarbital (Luminal)FDA Link 05/2019 - 01/2016
2	Aromatase InhibitorsIBA 10/2017 - 03/2013
2	CytokinesIBA 03/2017 - 01/2017
2	Indicators and Reagents (Reagents)IBA 08/2016 - 02/2016
2	Sirtuin 1IBA 02/2016 - 07/2015
1	130-nm albumin-bound paclitaxelIBA 04/2022
1	adavosertibIBA 04/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022
1	durvalumabIBA 01/2022
1	tremelimumabIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	avelumabIBA 01/2021
1	Thyroid HormonesIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 11/2020
1	Cytotoxins (Cytolysins)IBA 11/2020
1	OsteocalcinIBA 10/2020

Therapy/Procedure

54	Drug Therapy (Chemotherapy) 02/2022 - 10/2011
17	Therapeutics 01/2022 - 01/2015
13	Neoadjuvant Therapy 01/2022 - 12/2012
8	Adjuvant Chemotherapy 02/2022 - 10/2015
4	Combination Drug Therapy (Combination Chemotherapy) 11/2017 - 07/2005
2	Radiotherapy 12/2018 - 08/2016
2	Mastectomy (Mammectomy) 07/2017 - 04/2015
1	Immunotherapy 01/2022
1	Aftercare (After-Treatment) 10/2021
1	Drug Tapering 01/2021